Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma

Clinical trial NCT00960492 · COMPLETED

Trial details

NCT number: NCT00960492
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Giant Cell Glioblastoma Gliosarcoma

Start date: 2009-09-01
Primary completion: 2012-11-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.